← FDA Drug Approvals (Drugs@FDA)

LISDEXAMFETAMINE DIMESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2023-08-25

Drug application

FDA Application #

ANDA215415

Application type

Abbreviated New Drug Application (Generic)

Brand name

LISDEXAMFETAMINE DIMESYLATE

Generic name

LISDEXAMFETAMINE DIMESYLATE

Active ingredients

LISDEXAMFETAMINE DIMESYLATE

Dosage form

TABLET, CHEWABLE

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2023-08-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown